Funnily enough, that's my exact same average price for my...

Funnily enough, that's my exact same average price for my shares. I paid up to $2.68 for some of my earlier shares and then averaged down when the price was around the $1.20 mark. I have a total number of shares that I want to build up to and am 80% of the way there, but have learned to be a bit more patient. The big price mover will come from Xperience revenue growth, which I think will come in two waves. The first will be over the next year as the early adopters start to use the product. The bigger wave should begin to grow after the results of the key clinical studies are released in about a years time.

I firmly believe that patience, which is an all too uncommon trait in todays investor will be handsomely rewarded.